Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Radiology ; 301(3): 735-740, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34807772

RESUMEN

History A 55-year-old woman without systemic underlying disease, such as diabetes mellitus, inflammatory bowel disease, autoimmune disease, or chronic kidney disease, presented with generalized dull abdominal pain of 1-week duration. She had ingested herbal medicine for physical conditioning for several years. Laboratory findings, including biochemistry, electrolyte levels, and complete blood count, were all within normal limits, except for elevated serum C-reactive protein level (7.719 mg/dL; normal range, <1 mg/dL). The patient underwent initial evaluation with conventional abdominal radiography. She underwent subsequent evaluation with noncontrast CT of the abdomen and colonoscopy.


Asunto(s)
Colitis/complicaciones , Colitis/diagnóstico por imagen , Tomografía Computarizada por Rayos X/métodos , Calcificación Vascular/complicaciones , Calcificación Vascular/diagnóstico por imagen , Dolor Abdominal/etiología , Anticoagulantes/uso terapéutico , Colitis/tratamiento farmacológico , Colon/diagnóstico por imagen , Femenino , Humanos , Mucosa Intestinal/diagnóstico por imagen , Persona de Mediana Edad , Radiografía Abdominal , Calcificación Vascular/tratamiento farmacológico , Warfarina/uso terapéutico
2.
Radiology ; 300(2): 481-483, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34310227

RESUMEN

History A 55-year-old woman without systemic underlying disease, such as diabetes mellitus, inflammatory bowel disease, autoimmune disease, or chronic kidney disease, presented with generalized dull abdominal pain of 1-week duration. She had ingested herbal medicine for physical conditioning for several years. Laboratory findings, including biochemistry, electrolyte levels, and complete blood count, were all within normal limits, except for elevated serum C-reactive protein level (7.719 mg/dL; normal range,<1 mg/dL). The patient underwent initial evaluation with conventional abdominal radiography (Fig 1). She underwent subsequent evaluation with noncontrast CT of the abdomen (Figs 2, 3) and colonoscopy (Fig 4).

3.
Nutrients ; 12(4)2020 Apr 14.
Artículo en Inglés | MEDLINE | ID: mdl-32295272

RESUMEN

The liver is the main organ responsible for bacterial and endotoxin clearance. Pyroptosis is a form of proinflammatory programmed cell death activated by caspase-1/11 and gasdermin D (GadD). Pyroptosis protects the host against bacterial infection; however, overactive pyroptosis can lead to organ injury. Glutamine (GLN) is a specific amino acid with anti-inflammatory and immunomodulatory properties. This study investigated the effects of GLN pretreatment on liver pyroptosis in a mouse model of polymicrobial sepsis. Mice were assigned to sham, sepsis control (Sepsis-C), and sepsis GLN (Sepsis-G) groups. The sham and Sepsis-C groups were fed the AIN-93G diet. The Sepsis-G group was provided with identical diet components except that part of the casein was replaced by GLN. After feeding the respective diets for 2 weeks, a cecal ligation and puncture (CLP) procedure was performed in the sepsis groups. An antibiotic was administered after CLP. Mice were sacrificed at either 24 or 72 h after CLP. The results showed that sepsis resulted in upregulated liver caspase-1/11 expression. Compared to the Sepsis-C group, the Sepsis-G group had higher liver caspase-11 and NLRP3 gene expressions at 24 h and lower active caspase-1/11 and cleaved GadD protein levels at 72 h after sepsis. Additionally, liver inflammatory cytokine gene expressions had decreased by 72 h post-CLP. The findings suggest that prophylactic administration of GLN initially upregulated liver pyroptosis to eradicate pathogens, yet the process of pyroptosis was suppressed in the late phase of sepsis. This may have beneficially attenuated liver inflammation and injury in an antibiotic-treated septic condition.


Asunto(s)
Coinfección/fisiopatología , Coinfección/terapia , Suplementos Dietéticos , Glutamina/administración & dosificación , Glutamina/farmacología , Hígado/metabolismo , Piroptosis/efectos de los fármacos , Sepsis/fisiopatología , Sepsis/terapia , Animales , Antiinflamatorios , Caspasa 1/genética , Caspasa 1/metabolismo , Caspasas Iniciadoras/genética , Caspasas Iniciadoras/metabolismo , Coinfección/metabolismo , Modelos Animales de Enfermedad , Expresión Génica/efectos de los fármacos , Factores Inmunológicos , Inflamación , Hígado/fisiopatología , Masculino , Ratones Endogámicos C57BL , Proteína con Dominio Pirina 3 de la Familia NLR/genética , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Sepsis/metabolismo
4.
Front Pharmacol ; 11: 601785, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33519464

RESUMEN

Over the past decade, the rise of cancer immunotherapy has coincided with a remarkable breakthrough in cancer therapy, which attracted increased interests in public. The scientific community clearly showed that the emergence of immunotherapy is an inevitable outcome of a holistic approach for cancer treatment. It is well established that traditional Chinese medicine (TCM) utilizes the principle of homeostasis and balance to adjust the healthy status of body. TCM treatment toward cancer has a long history, and the diagnosis and treatment of tumors were discussed in the ancient and classical literatures of Chinese medicine, such as the Yellow Emperor's Inner Canon. Precious heritage has laid the foundation for the innovation and development of cancer treatment with TCM. The modern study indicated that TCM facilitates the treatment of cancer and enhances the survival rate and life expectancy of patients. However, the pharmacological mechanisms underlying these effects are not yet completely understood. In addition, physicians cannot always explain why the TCM treatment is effective and the mechanism of action cannot be explained in scientific terms. Here, we attempted to provide insights into the development of TCM in the treatment and interpret how TCM practitioners treat cancer through six general principles of TCM by using modern scientific language and terms based on newly discovered evidence.

5.
Molecules ; 24(20)2019 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-31619002

RESUMEN

The prevalence of upper tract urothelial carcinoma (UTUC) in Taiwan is relatively higher than thatin Western countries. Aristolochic acid (AA), which is widely used in traditional Chinese herbology, is now recognized to be one of the carcinogens for UTUC. Numerous UTUC patients have chronic kidney diseases or end-stage renal diseases; however, little literature hasreported on theoncogenic pathway of AA-related UTUC. The aim of our study was to identify the potential target treatment for AA-related UTUC. Here, we established an AA pre-exposure followed bya 3-methylcholanthrene (MCA) stimulus tumorigenic cell model. We not only demonstrated that AA pre-exposure MCA stimulus tumorigenic cells have more behaviors of cell migration and invasion by enhancing the metalloproteinases (MMP) activity, which is compatible with clinical findings of AA-related UTUC, but we also validated that AA pre-exposure MCA stimulus tumorigeniccells could be activated through the mitogen-activated protein kinases (MAPK) pathway. We further dissected the route of the MAPK pathway and found that the p38 and extracellular signal regulated kinases (ERK) sub-pathways might play essential roles in AA pre-exposure urothelial cancer cell lines. This consequence was also corroborated with a tissue study in AA-exposed patients.


Asunto(s)
Ácidos Aristolóquicos/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Neoplasias Urológicas/metabolismo , Urotelio/metabolismo , Urotelio/patología , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Transformación Celular Neoplásica/metabolismo , Humanos , Metaloproteinasas de la Matriz/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Neoplasias Urológicas/tratamiento farmacológico , Neoplasias Urológicas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA